Skip to content
The Nexus
DossierENTITY

structural heart disease

Coverage of structural heart disease in the Nexus archive.

Earliest in view: Jun 23 · 08:30 UTCMost recent: Jun 23 · 08:30 UTC
Co-mentioned in this coverage
New York-Presbyterian Hospitalorganization1Pathway Labsorganization1OpenEvidenceorganization1EchoNexttopic1Food and Drug Administrationorganization1EKGtopic1
Recent coverage
  • HEALTHJun 23 · 08:30 UTCSTAT NEWS
    STAT+: A sweeping new AI to detect heart conditions is coming to OpenEvidence

    EchoNext, an AI model developed by New York-Presbyterian Hospital researchers and commercialized by Pathway Labs, has received FDA clearance to detect seven forms of structural heart disease from EKGs. Pathway Labs will license the technology to OpenEvidence, a medical evidence search engine used by hundreds of thousands of clinicians.